Login

Interview with John Lai, CEO & President of PetVivo Holdings, Inc., highlighting company insights and future plans. 00:10:00

Share On Facebook Share On Twitter

John Lai is Pres/CEO/IR/Co-Founder, Petvivo Holdings Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Designing 91 Squarefeet of startup success|Amit Bansal,Partner,Digitalis Ventures
00:10:00
AAK AB Q2 2019 Report: CFO Fredrik Nilsson's Commentary | Fredrik Nilsson, CFO , AAK AB.
00:10:00
Revival Gold: Building a Growth Company in Idaho
00:10:00
Inside Google: Sundar Pichai on AI, Innovation, and the Future| Sundar Pichai, CEO, Google
00:10:00
CEOTalks featuring Tomás Córdoba, Presidente y Director General of MetroGAS, discuss industry insights and innovations.
00:10:00
Outlook for the Future|Hans Tung,Managing Partner,GGV Capital
00:10:00
Exploring Viva Gold Corp's Tonopah Gold Project: An Interview with CEO James Hesketh | James Hesketh - Chief Executive Officer & Director of Viva Gold Corp.
00:10:00
Kimpur CEO Cavidan Karaca Discusses the Company’s Growth and Future Outlook | Cavidan Karaca ,CEO , Kimpur.
00:10:00
Computing the future of medicine|Alan Whitmore,Chief Scientific Officer,E Therapeutics
00:00:00
Sam Farres, M.D. Vascular Surgeon, Mayo Clinic
00:10:00
Empowering Women in Finance: Sallie Krawcheck's Journey
00:10:00
Tinkering with Appliances to Transforming Clinical Trials|Ryan Jones,CEO,Florence Healthcare

© 2017 - Neuhu+